(NASDAQ: SWAV) Shockwave Medical's forecast annual revenue growth rate of 22.15% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Shockwave Medical's revenue in 2024 is $730,230,000.On average, 7 Wall Street analysts forecast SWAV's revenue for 2024 to be $34,449,460,741, with the lowest SWAV revenue forecast at $34,225,566,003, and the highest SWAV revenue forecast at $34,593,251,498. On average, 7 Wall Street analysts forecast SWAV's revenue for 2025 to be $41,963,415,995, with the lowest SWAV revenue forecast at $40,544,132,035, and the highest SWAV revenue forecast at $43,899,673,541.
In 2026, SWAV is forecast to generate $49,855,153,885 in revenue, with the lowest revenue forecast at $48,204,495,824 and the highest revenue forecast at $53,031,976,008.